Ali Asif Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$2.97M

Insider Activity of Ali Asif

According to the SEC Form 4 filings, Ali Asif, being in a position of

  1. Chief Financial Officer at Protagonist Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 139935 shares for $15.63M,
    over all time since 2024-02-29, has bought 0 shares, and sold 210136 shares for $18.6M.

Biography of Ali Asif

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$15,627,7455100

Comparison of Insiders on Amount of Buys and Sells

2026-09-30SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
58,629
0.0917%
$141.78$8.31M-0.83%
2026-04-20SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
1,750
0.0027%
$105.47$184,573+29.47%
2026-03-26SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
24,765
0.0396%
$104.24$2.58M+31.58%
2026-01-27SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
46,203
0.074%
$83.13$3.84M+34.75%
2026-01-20SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
8,588
0.0136%
$82.48$708,338+31.61%
2025-04-22SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
1,756
0.003%
$46.00$80,776+66.85%
2025-03-12SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
24,903
0.0413%
$58.73$1.46M+2.72%
2025-01-16SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
3,918
–
$0$0+51.12%
2024-09-11SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
14,203
0.0239%
$44.49$631,872+2.49%
2024-04-18SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
1,234
0.0021%
$25.11$30,986+56.72%
2024-03-01SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
14,248
0.0247%
$32.24$459,318+17.67%
2024-02-29SaleProtagonist Therapeutics, Inc.
PTGX
Chief Financial Officer
9,939
0.0174%
$30.69$305,048+24.47%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.